Why is the iPledge Program Important in Epidemiology?
From an epidemiological perspective, the iPledge program addresses the public health concern of teratogenicity. The primary goal is to reduce the incidence of birth defects associated with isotretinoin use. By systematically monitoring and controlling its distribution, the program aims to mitigate the risk factors that contribute to adverse pregnancy outcomes.
